ACET Earnings Preview: Options Price a ±1.3% Move
· The NYC Memo · ACET reports 2026-11-04
Adicet Bio, Inc. reports November 4, 2026. The November 20, 2026 straddle implies ±1.26% against a 7.31% average reaction, with dealers long gamma and max pain at $7.5.
Live updates
Nov 4 — Ahead of November 4, 2026 earnings, ACET options price a 1.26% move as at-the-money implied volatility fell from 199.6% to 179.3% and put/call open interest rose from 4.69 to 4.85, reflecting shrinking event volatility alongside increased downside hedging.
Nov 3 — Ahead of November 4 earnings, the ACET implied move decreased from ±42.40% to ±1.25% as spot fell from $3.42 to $3.20, implying that the options market expects significantly subdued price volatility following the report.
Adicet Bio, Inc. reports on November 4, 2026, with spot at $3.17. The November 20, 2026 straddle costs $0.04, reflecting an implied move of 1.26% and an implied range of $3.13 to $3.21 at an implied volatility of 179.3%. This pricing sits well below historical performance. Across 8 prints counted, the average realised reaction is 7.31%, with 3 higher and 5 lower sessions.
Ahead of the print, put-call open interest is 4.85 with max pain at $7.5. Dealer lean sits in long gamma, which dampens price swings as market makers hedge directional movement. The stock enters the release down -51.0% over the past month and -73.2% from its 52-week high.
What the market will be watching
Adicet Bio investors will focus on clinical progress across the gamma delta cell therapy pipeline and associated development expenses. The market seeks clarity on ongoing trial enrollment trends and partner demand for core oncology programs. Operating costs remain critical as research spending pressures cash reserves and operational margins. Traders will evaluate updated guidance regarding pipeline milestones and projected capital runway through year end. Commentary on regulatory interactions, patient safety profiles, and allogeneic manufacturing scalability will drive the immediate options reaction.
What the options market is pricing
| Measure | Level |
|---|---|
| November 4, 2026 | |
| Expiry used | November 20, 2026 (16 days out) |
| Spot | $3.17 |
| ATM straddle | $0.04 |
| Implied move | ±1.26% ($3.13 to $3.21) |
| ATM implied vol | 179.3% |
| Put/call open interest | 4.85 |
| Max pain | $7.5 |
| Net dealer gamma | +$0.00mn per 1% move, LONG GAMMA |
| Heaviest call strike above spot | $12.5 (10 contracts) |
| Heaviest put strike below spot | $2.5 (11 contracts) |
Dealers sit long gamma into the print, which means their hedging leans against the move and tends to compress ACET between catalysts. That damping disappears the moment the number crosses the tape.
How the stock has reacted before
| Report | Next-day move |
|---|---|
| Q2 2026, Aug 5 | -13.43% |
| Q1 2026, May 13 | +4.21% |
| Q4 2025, Mar 12 | +2.41% |
| Q3 2025, Nov 5 | -1.91% |
| Q2 2025, Aug 7 | -9.62% |
| Q1 2025, May 6 | -18.65% |
| Q4 2024, Mar 6 | -5.90% |
| Q3 2024, Nov 6 | +2.31% |
Across the last 8 prints the average absolute reaction is 7.31%, with 3 higher and 5 lower. The best was +4.21% and the worst -18.65%. Options are asking ±1.26%, which is 6.05 points cheaper than the realised average, the premium buyer's case.
Where the stock is trading
| Measure | Level |
|---|---|
| Spot | $3.17 |
| 52-week range | $3.13 to $11.82 |
| Position in that range | 0% |
| From the 52-week high | -73.2% |
| From the 52-week low | +1.3% |
| Past week | -16.8% |
| Past month | -51.0% |
| Past three months | -65.4% |
| 50-day average | $6.91 |
| 200-day average | $7.64 |
How the options market is pricing it
The November 20, 2026 straddle marks $3.13 to $3.21 as the range the options market is paying for into the print, with ATM implied vol at 179% set to drain the morning after. A reaction inside that band hands the edge to premium sellers; a break outside it rewards premium buyers. Historically ACET has moved 7.31% on earnings against the ±1.26% now implied, so the market is pricing this print cheaper than the recent average. Which side of that trade is right depends on the number, the guidance and where positioning unwinds.
Read the mechanics behind the crush in our earnings volatility guide, and pull the live memo for ACET before the print.
Data as of November 4, 2026 from the live option chain, exchange price history and SEC-dated earnings reactions. This is research, not investment advice.
Related: ACET options memo